Cost effectiveness analysis of continuous glucose monitoring versus self-monitoring of blood glucose in type 2 diabetes patients in Iran
CGM does not represent a cost-effective alternative to SMBG for patients with T2D in Iran. This finding was supported by bootstrap analysis, which demonstrated a lack of cost-effectiveness across all simulated scenarios.
Authors
- Alireza Olyaeemanesh (ORCID: https://orcid.org/0000-0002-7417-2417)
- Amin Mohammadi (ORCID: https://orcid.org/0000-0002-0576-4099)
- Abdoreza Mousavi (ORCID: https://orcid.org/0000-0001-8786-7309)
- Rajabali Daroudi (ORCID: https://orcid.org/0000-0002-0487-4114)
- Ali Darvishi (ORCID: https://orcid.org/0000-0002-3173-9065)
- Amirhossein Takian (ORCID: https://orcid.org/0000-0002-3955-1040)
- Ramin Heshmat
- Ensieh Nasli-Esfahani (ORCID: https://orcid.org/0000-0002-4054-7516)
- Gita Shafiee
Institutions
- Iran University of Medical Sciences (IR)
- Shahid Beheshti University of Medical Sciences (IR)
- Tehran University of Medical Sciences (IR)
Publication Details
- Journal
- Expert Review of Pharmacoeconomics & Outcomes Research
- Published
- 2025-11-07
- DOI
- https://doi.org/10.1080/14737167.2025.2586670
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00